17β-estradiol activates HSF1 via MAPK signaling in erα-positive breast cancer cells

23Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Heat Shock Factor 1 (HSF1) is a key regulator of gene expression during acute environmental stress that enables the cell survival, which is also involved in different cancer-related processes. A high level of HSF1 in estrogen receptor (ER)-positive breast cancer patients correlated with a worse prognosis. Here we demonstrated that 17β-estradiol (E2), as well as xenoestrogen bisphenol A and ERα agonist propyl pyrazole triol, led to HSF1 phosphorylation on S326 in ERα positive but not in ERα-negative mammary breast cancer cells. Furthermore, we showed that MAPK signaling (via MEK1/2) but not mTOR signaling was involved in E2/ERα-dependent activation of HSF1. E2activated HSF1 was transcriptionally potent and several genes essential for breast cancer cells growth and/or ERα action, including HSPB8, LHX4, PRKCE, WWC1, and GREB1, were activated by E2 in a HSF1-dependent manner. Our findings suggest a hypothetical positive feedback loop between E2/ERα and HSF1 signaling, which may support the growth of estrogen-dependent tumors.

Cite

CITATION STYLE

APA

Vydra, N., Janus, P., Toma-Jonik, A., Stokowy, T., Mrowiec, K., Korfanty, J., … Widłak, W. (2019). 17β-estradiol activates HSF1 via MAPK signaling in erα-positive breast cancer cells. Cancers, 11(10). https://doi.org/10.3390/cancers11101533

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free